INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $346,555 | -83.0% | 10,960 | -78.1% | 0.00% | -83.3% |
| Q2 2023 | $2,042,179 | +47.2% | 50,078 | +34.5% | 0.02% | +38.5% |
| Q1 2023 | $1,387,447 | +12.7% | 37,227 | +69.4% | 0.01% | +30.0% |
| Q3 2022 | $1,231,000 | -47.0% | 21,970 | -51.1% | 0.01% | -56.5% |
| Q2 2022 | $2,324,000 | +33.9% | 44,900 | +87.9% | 0.02% | +43.8% |
| Q1 2022 | $1,736,000 | -54.6% | 23,900 | +1.3% | 0.02% | -61.0% |
| Q2 2021 | $3,822,000 | +120.4% | 23,600 | -26.0% | 0.04% | +78.3% |
| Q4 2020 | $1,734,000 | +688.2% | 31,880 | +179.1% | 0.02% | +27.8% |
| Q4 2017 | $220,000 | -1.3% | 11,424 | +9.4% | 0.02% | -64.0% |
| Q2 2016 | $223,000 | – | 10,443 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |